Surgery Partners Inc [SGRY] stock is trading at $22.9, up 0.44%. An important factor to consider is whether the stock is rising or falling in short-term value. The SGRY shares have gain 9.83% over the last week, with a monthly amount glided 4.81%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
On December 16, 2024, BofA Securities initiated with a Buy rating and assigned a price target of $30 on the stock. UBS started tracking the stock assigning a Buy rating and suggested a price target of $38 on October 14, 2024. KeyBanc Capital Markets initiated its recommendation with a Sector Weight. Macquarie started tracking with a Outperform rating for this stock on June 28, 2024, and assigned it a price target of $31. In a note dated March 06, 2024, Barclays initiated an Equal Weight rating and provided a target price of $35 on this stock.
Surgery Partners Inc [SGRY] stock has fluctuated between $18.87 and $31.89 over the past year. Currently, Wall Street analysts expect the stock to reach $40.8 within the next 12 months. Surgery Partners Inc [NASDAQ: SGRY] shares were valued at $22.9 at the most recent close of the market. An investor can expect a potential return of 78.17% based on the average SGRY price forecast.
Analyzing the SGRY fundamentals
Surgery Partners Inc [NASDAQ:SGRY] reported sales of 3.24B for the trailing twelve months, which represents a growth of 8.41%. Gross Profit Margin for this corporation currently stands at 0.24% with Operating Profit Margin at 0.11%, Pretax Profit Margin comes in at 0.04%, and Net Profit Margin reading is -0.06%. To continue investigating profitability, this company’s Return on Assets is posted at -0.02, Equity is -0.1 and Total Capital is 0.05. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of2.22.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 22.60 points at the first support level, and at 22.30 for the second support level. However, for the 1st resistance point, the stock is sitting at 23.19, and for the 2nd resistance point, it is at 23.49.
Ratios To Look Out For
For context, Surgery Partners Inc’s Current Ratio is 1.93. On the other hand, the Quick Ratio is 1.78, and the Cash Ratio is 0.44. Considering the valuation of this stock, the price to sales ratio is 0.91, the price to book ratio is 1.68.
Transactions by insiders
Recent insider trading involved Wayne DeVeydt, former director, that happened on Oct 24 ’25 when 2913.0 shares were purchased. former director, Wayne DeVeydt completed a deal on Oct 23 ’25 to buy 30948.0 shares. Meanwhile, former director Wayne DeVeydt bought 25052.0 shares on Oct 22 ’25.
